Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib

NCT02786342 · clinicaltrials.gov ↗

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: blood sample collection

Sponsor

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS